1. 319 Phase II trial of immunotherapy in primary glioblastoma: antigens from self-renewing autologous tumor cells presented by autologous dendritic cell vaccine. (9th November 2020) Authors: Bota, Daniela; Piccioni, David; Duma, Christopher; LaRocca, Renato; Kesari, Santosh; Carrillo, Jose; O'Donnell, Robert; Aiken, Robert; Hsu, Frank; Kong, Xiao-Tang; Taylor, Thomas; Nistor, Gabriel; Dillman, Robert Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A345 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 319 Phase II trial of immunotherapy in primary glioblastoma: antigens from self-renewing autologous tumor cells presented by autologous dendritic cell vaccine. (9th November 2020) Authors: Bota, Daniela; Piccioni, David; Duma, Christopher; LaRocca, Renato; Kesari, Santosh; Carrillo, Jose; O'Donnell, Robert; Aiken, Robert; Hsu, Frank; Kong, Xiao-Tang; Taylor, Thomas; Nistor, Gabriel; Dillman, Robert Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A196 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. ATIM-02. DURABLE RESPONSES OBSERVED IN IDH1 WILDTYPE AND MUTANT RECURRENT HIGH GRADE GLIOMA (rHGG) WITH TOCA 511 & TOCA FC TREATMENT. Issue 11 (6th November 2017) Authors: Cloughesy, Timothy; Landolfi, Joseph; Vogelbaum, Michael; Ostertag, Derek; Elder, Bradley; Carter, Bob; Chen, Clark; Kalkanis, Steven; Lai, Albert; Mikkelsen, Tom; Nghiemphu, Phioanh; Piccioni, David; Accomando, William; Diago, Oscar; Hogan, Daniel; Jolly, Douglas; Wood, Katie; Yang, Liqiang; Gru... Journal: Neuro-oncology Issue: Volume 19:Issue 11(2017)supplement 6 Page Start: vi26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Bevacizumab as first-line therapy for glioblastoma. (August 2012) Authors: Piccioni, David; Lai, Albert; Nghiemphu, Phioanh; Cloughesy, Timothy Journal: Future oncology Issue: Volume 8:Number 8(2012) Page Start: 929 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Bevacizumab as first-line therapy for glioblastoma. (August 2012) Authors: Piccioni, David; Lai, Albert; Nghiemphu, Phioanh; Cloughesy, Timothy Journal: Future oncology Issue: Volume 8:Number 8(2012) Page Start: 929 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. BIOM-05. THE HER2 FLIP: HER2 AMPLIFICATION OF TUMOR CELLS IN THE CEREBROSPINAL FLUID (CSF-TCS) OF PATIENTS WITH SOLID TUMOR LEPTOMENINGEAL METASTASIS. (14th November 2022) Authors: Kumthekar, Priya; Youssef, Michael; Blondin, Nicholas; Azadi, Amir; Piccioni, David; Glantz, Michael; Carillo, Jose; Sharma, Akanksha; Avgeropoulos, Nicholas; Makar, Sherif; Blouw, Barbara; Natasha, Anna; Fisher, Deanna; Huynh, Lan; Peters, John; Matsutani, Mariko; Sales, Edgar; Sweed, Nathan; Du... Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. CTIM-26. PATIENT-SPECIFIC DENDRITIC CELL VACCINE (DC-ATA) PULSED WITH ANTIGENS FROM SELF-RENEWING AUTOLOGOUS TUMOR CELLS IN THE TREATMENT OF NEWLY-DIAGNOSED GLIOBLASTOMA: A PHASE II TRIAL. (9th November 2020) Authors: Bota, Daniela; Piccioni, David; LaRocca, R; Duma, Christopher; Kesari, Santosh; Carrillo, Jose; O'Donnell, Robert T; Aiken, Robert; Hsu, Frank; Kong, Xiao-Tang; Hsieh, Candace; Langford, Chris; Carta, Krystal; Wang, Adrienne; Langford, James; Taylor, Thomas; Nistor, Gabriel; Dillman, Robert Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. CTNI-03. EXTENDED BENEFITS IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA THAT CONTINUOUSLY RECEIVE TOCA FC AFTER TOCA 511 TREATMEN. (12th November 2021) Authors: Walbert, Tobias; Damek, Denise; Nina, L Martinez; Piccioni, David; Singer, Samuel; Cloughesy, Timothy Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. CTNI-08. DB102-01 ENGAGE STUDY: A BIOMARKER-GUIDED, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER PHASE 3 CLINICAL TRIAL OF DB102 IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM). (12th November 2021) Authors: Bota, Daniela; Butowski, Nicholas; Piccioni, David; De la Fuente, Macarena; Mao, Ying; Li, Wen-Bin; Trusheim, John; Fink, Karen; Campian, Jian; Lobbous, Mina; Portnow, Jana; Zhu, Jay-Jiguang; Pearlman, Michael; Rudnick, Jeremy; Lesser, Glen; Drappatz, Jan; Vaillant, Brian; Sun, Show-Li; Luo, Wen Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. CTNI-23. PRELIMINARY SAFETY AND PHARMACOKINETICS DATA FOR A PHASE 1B TRIAL OF TELAGLENASTAT IN COMBINATION WITH RADIATION THERAPY AND TEMOZOLOMIDE IN PATIENTS WITH IDH-MUTANT GRADE 2/3 ASTROCYTOMA (NCI-10218). (14th November 2022) Authors: Kizilbash, Sani; Piccioni, David; Sahebjam, Solmaz; Villano, John; Jaeckle, Kurt; Welch, Mary; Kong, Xiao-Tang; Holdhoff, Matthias; Lammers, Anita; Remick, Adam; Reid, Joel; Allred, Jacob; Port, John; Lanza, Ian; McBrayer, Samuel; Kunos, Charles; Shapiro, Geoffrey; Adjei, Alex Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii75 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗